A bioactive ginsenoside alleviates hepatocellular ferroptosis induced by oxidized phospholipid accumulation in nonalcoholic steatohepatitis

References

[1] Younossi, Zobair, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, et al. 2019. “Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.” Hepatology 69: 2672–82. https://doi.org/10.1002/hep.30251

[2] Dufour, Jean-François, Cyrielle Caussy, and Rohit Loomba. 2020. “Combination Therapy for Non-Alcoholic Steatohepatitis: Rationale, Opportunities and Challenges.” Gut 69: 1877–84. https://doi.org/10.1136/gutjnl-2019-319104

[3] Chalasani, Naga, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt, and Arun J. Sanyal. 2018. “The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases.” Hepatology 67: 328–57. https://doi.org/10.1002/hep.29367

[4] Huang, Wen-Chung, Tse-Hung Huang, Kuo-Wei Yeh, Ya-Ling Chen, Szu-Chuan Shen, and Chian-Jiun Liou. 2021. “Ginsenoside Rg3 Ameliorates Allergic Airway Inflammation and Oxidative Stress in Mice.” Journal of Ginseng Research 45: 654–64. https://doi.org/10.1016/j.jgr.2021.03.002

[5] Xia, Jiaxuan, Shaojie Ma, Xi Zhu, Chen Chen, Ru Zhang, Zhonglian Cao, Xing Chen, et al. 2022. “Versatile Ginsenoside Rg3 Liposomes Inhibit Tumor Metastasis by Capturing Circulating Tumor Cells and Destroying Metastatic Niches.” Science Advances 8: eabj1262. https://doi.org/10.1126/sciadv.abj1262

[6] Que, Xuchu, Ming-Yow Hung, Calvin Yeang, Ayelet Gonen, Thomas A. Prohaska, Xiaoli Sun, Cody Diehl, et al. 2018. “Oxidized Phospholipids Are Proinflammatory and Proatherogenic in Hypercholesterolaemic Mice.” Nature 558: 301–6. https://doi.org/10.1038/s41586-018-0198-8

[7] Rouhanizadeh, Mahsa, Juliana Hwang, Roza E. Clempus, Laura Marcu, Bernard Lassègue, Alex Sevanian, and Tzung K. Hsiai. 2005. “Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine Induces Vascular Endothelial Superoxide Production: Implication of NADPH Oxidase.” Free Radical Biology and Medicine 39: 1512–22. https://doi.org/10.1016/j.freeradbiomed.2005.07.013

[8] Van Lenten, Brian J., Alan C. Wagner, Mohamad Navab, and Alan M. Fogelman. 2001. “Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6.” Journal of Biological Chemistry 276: 1923–9. https://doi.org/10.1074/jbc.M004074200

[9] Stockwell, Brent R., Xuejun Jiang, and Wei Gu. 2020. “Emerging Mechanisms and Disease Relevance of Ferroptosis.” Trends in Cell Biology 30: 478–90. https://doi.org/10.1016/j.tcb.2020.02.009

[10] Sun, Xiaoli, Jason S. Seidman, Peng Zhao, Ty D. Troutman, Nathanael J. Spann, Xuchu Que, Fangli Zhou, et al. 2020. “Neutralization of Oxidized Phospholipids Ameliorates Non-Alcoholic Steatohepatitis.” Cell Metabolism 31: 189–206.e8. https://doi.org/10.1016/j.cmet.2019.10.014

[11] Tilg, Herbert, Timon E. Adolph, Michael Dudek, and Percy Knolle. 2021. “Non-Alcoholic Fatty Liver Disease: The Interplay Between Metabolism, Microbes and Immunity.” Nature Metabolism 3: 1596–607. https://doi.org/10.1038/s42255-021-00501-9

[12] Liang, Deguang, Yan Feng, Fereshteh Zandkarimi, Hua Wang, Zeda Zhang, Jinnie Kim, Yanyan Cai, et al. 2023. “Ferroptosis Surveillance Independent of GPX4 and Differentially Regulated by Sex Hormones.” Cell 186: 2748–64.e22. https://doi.org/10.1016/j.cell.2023.05.003

[13] Hu, Yunhong, Yang Wang, Fei Wang, Yan-Ming Dong, Wan-Ling Jiang, Ya-Ping Wang, Xing Zhong, et al. 2021. “SPOP Negatively Regulates Toll-Like Receptor-Induced Inflammation by Disrupting MyD88 Self-Association.” Cellular & Molecular Immunology 18: 1708–17. https://doi.org/10.1038/s41423-020-0411-1

[14] Song, Yizuo, Yichi Xu, Chunyu Pan, Linzhi Yan, Zhiwei Wang, and Xueqiong Zhu. 2020. “The Emerging Role of SPOP Protein in Tumorigenesis and Cancer Therapy.” Molecular Cancer 19: 2. https://doi.org/10.1186/s12943-019-1124-x

[15] Zhou, Peng, Wenyi Chang, De-Ao Gong, Luyi Huang, Rui Liu, Yi Liu, Jie Xia, et al. 2023. “O-Glcnacylation of SPOP Promotes Carcinogenesis in Hepatocellular Carcinoma.” Oncogene 42: 725–36. https://doi.org/10.1038/s41388-022-02589-z

[16] Kim, Ji Yeon, Keon Jae Park, Joo-Yeon Hwang, Gyu Hee Kim, DaeYeon Lee, Yoo Jeong Lee, Eun Hyun Song, et al. 2017. “Activating Transcription Factor 3 Is a Target Molecule Linking Hepatic Steatosis to Impaired Glucose Homeostasis.” Journal of Hepatology 67: 349–59. https://doi.org/10.1016/j.jhep.2017.03.023

[17] Shi, Zhemin, Kun Zhang, Ting Chen, Yu Zhang, Xiaoxiao Du, Yanmian Zhao, Shuai Shao, et al. 2020. “Transcriptional Factor ATF3 Promotes Liver Fibrosis via Activating Hepatic Stellate Cells.” Cell Death & Disease 11: 1066. https://doi.org/10.1038/s41419-020-03271-6

[18] Wang, Liyuan, Yichen Liu, Tingting Du, Heng Yang, Lei Lei, Mengqi Guo, Han-Fei Ding, et al. 2020. “ATF3 Promotes Erastin-Induced Ferroptosis by Suppressing System Xc.” Cell Death & Differentiation 27: 662–75. https://doi.org/10.1038/s41418-019-0380-z

[19] Zhan, Yizhi, Zhanqiao Zhang, Yuechen Liu, Yuan Fang, Yuwen Xie, Yilin Zheng, Guoxin Li, Li Liang, and Yi Ding. 2022. “NUPR1 Contributes to Radiation Resistance by Maintaining ROS Homeostasis via AhR/CYP Signal Axis in Hepatocellular Carcinoma.” BMC Medicine 20: 365. https://doi.org/10.1186/s12916-022-02554-3

[20] Liu, Jiao, Xinxin Song, Feimei Kuang, Qiuhong Zhang, Yangchun Xie, Rui Kang, Guido Kroemer, and Daolin Tang. 2021. “NUPR1 Is a Critical Repressor of Ferroptosis.” Nature Communications 12: 647. https://doi.org/10.1038/s41467-021-20904-2

RIGHTS & PERMISSIONS

2026 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.